June 18, 2024

Dr. Barbara Burtness and colleagues highlight progress in head and neck cancer MRD at ASCO, but caution that results remain preliminary (free registration is required to view this article)

June 14, 2024

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

June 13, 2024

Nivolumab fails to benefit esophageal cancer treatment in the EA2174 trial: Dr. Jennifer Eads

June 13, 2024

Dr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)

June 13, 2024

Personalizing chemotherapy for Black women in study EAZ171 (story by the Susan G. Komen organization)

June 13, 2024

EAZ171 trial suggests Black patients with breast cancer have lower risk of taxane-induced peripheral neuropathy with docetaxel than paclitaxel

June 13, 2024

Study EAZ171 suggests docetaxel is superior for neuropathy in Black patients with breast cancer

May 16, 2024

CompassHER2 pCR trial to evaluate the HER2DX® score

May 14, 2024

ECOG-ACRIN research at ASCO 2024

ECOG-ACRIN Cancer Research Group